Dimensional Fund Advisors
VIVO

Dimensional Fund Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Dimensional Fund Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,791,282
Closed -$59.5K – 3553
2022
Q4 		$59.5K Sell
1,791,282
-11,845
-0.7% -$382K 0.02% 1191
2022
Q3 		$56.9M Sell
1,803,127
-130,964
-7% -$4.24M 0.02% 1117
2022
Q2 		$58.8M Buy
1,934,091
+28,876
+2% +$781K 0.02% 1155
2022
Q1 		$49.5M Buy
1,905,215
+18,832
+1% +$448K 0.02% 1418
2021
Q4 		$38.5M Buy
1,886,383
+28,451
+2% +$546K 0.01% 1597
2021
Q3 		$35.7M Buy
1,857,932
+35,423
+2% +$706K 0.01% 1663
2021
Q2 		$40.4M Sell
1,822,509
-7,443
-0.4% -$158K 0.01% 1603
2021
Q1 		$48M Sell
1,829,952
-66,615
-4% -$1.58M 0.02% 1475
2020
Q4 		$35.4M Sell
1,896,567
-178,396
-9% -$3.33M 0.01% 1645
2020
Q3 		$35.2M Sell
2,074,963
-4,026
-0.2% -$78.2K 0.01% 1472
2020
Q2 		$48.4M Buy
2,078,989
+50,772
+3% +$736K 0.02% 1224
2020
Q1 		$17M Buy
2,028,217
+11,667
+0.6% +$98.2K 0.01% 1847
2019
Q4 		$19.7M Buy
2,016,550
+50,796
+3% +$477K 0.01% 2052
2019
Q3 		$18.7M Buy
1,965,754
+20,860
+1% +$220K 0.01% 2056
2019
Q2 		$23.1M Buy
1,944,894
+24,483
+1% +$295K 0.01% 1969
2019
Q1 		$33.8M Buy
1,920,411
+18,848
+1% +$314K 0.01% 1748
2018
Q4 		$33M Buy
1,901,563
+14,871
+0.8% +$254K 0.02% 1655
2018
Q3 		$28.1M Buy
1,886,692
+58,358
+3% +$905K 0.01% 1922
2018
Q2 		$29.1M Buy
1,828,334
+9,714
+0.5% +$145K 0.01% 1889
2018
Q1 		$25.8M Buy
1,818,620
+30,913
+2% +$457K 0.01% 1909
2017
Q4 		$25M Buy
1,787,707
+38,859
+2% +$569K 0.01% 1945
2017
Q3 		$25M Buy
1,748,848
+80,877
+5% +$1.16M 0.01% 1911
2017
Q2 		$26.3M Buy
1,667,971
+240,143
+17% +$3.46M 0.01% 1848
2017
Q1 		$19.7M Buy
1,427,828
+29,755
+2% +$416K 0.01% 2007
2016
Q4 		$24.7M Sell
1,398,073
-923
-0.1% -$16.2K 0.01% 1820
2016
Q3 		$27M Buy
1,398,996
+10,643
+0.8% +$208K 0.01% 1669
2016
Q2 		$27.1M Buy
1,388,353
+24,075
+2% +$472K 0.02% 1591
2016
Q1 		$28.1M Buy
1,364,278
+84,960
+7% +$1.67M 0.02% 1528
2015
Q4 		$26.3M Buy
1,279,318
+75,432
+6% +$1.45M 0.02% 1535
2015
Q3 		$20.6M Buy
1,203,886
+167,962
+16% +$3.07M 0.01% 1720
2015
Q2 		$19.3M Buy
1,035,924
+204,043
+25% +$3.78M 0.01% 1880
2015
Q1 		$15.9M Buy
831,881
+75,130
+10% +$1.39M 0.01% 1980
2014
Q4 		$12.5M Buy
756,751
+99,290
+15% +$1.7M 0.01% 2115
2014
Q3 		$11.6M Buy
657,461
+113,851
+21% +$2.24M 0.01% 2088
2014
Q2 		$11.2M Buy
543,610
+96,208
+22% +$1.98M 0.01% 2135
2014
Q1 		$9.75M Buy
447,402
+65,373
+17% +$1.5M 0.01% 2208
2013
Q4 		$10.1M Buy
382,029
+91,765
+32% +$2.26M 0.01% 2157
2013
Q3 		$6.87M Buy
290,264
+132,780
+84% +$3.1M 0.01% 2378
2013
Q2 		$3.39M Buy
+157,484
New +$3.4M ﹤0.01% 2655

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Dimensional Fund Advisors's VIVO Position: Q1 2023 in Review

Dimensional Fund Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 1,791,282 shares — an estimated $59.5K sold.

Dimensional Fund Advisors first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $58.8M in Q2 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Dimensional Fund Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1,791,282 Meridian Bioscience Inc shares in Q1 2023, an estimated $59.5K.
  • Dimensional Fund Advisors first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • Dimensional Fund Advisors's Meridian Bioscience Inc position peaked at $58.8M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.